Flagship Biosciences: Gina Wallar

Gina Wallar has been appointed as chief commercial officer of Flagship Biosciences. She joins the spatial biology and biomarker analytics services firm from Fulgent Genetics, where she was senior VP of sales and business development. Prior to that, she held various positions at NeoGenomics Laboratories, most recently president of pharma services, and before that she was director at LabCorp Clinical Trials in Los Angeles. Wallar holds a PhD in molecular epidemiology from the University of California, Los Angeles and an MPH in epidemiology and biostatistics from Boston University.